Successful fibrinolytic therapy depends on delivering a high local concentration of
plasminogen activator to the site of thrombosis to acн celerate conversion of plasminogen to …

THE Society of Interventional Radiology (SIR) celebrates its 30th anniversary this year.
During these 30 years, SIR has grown from a closed club with fewer than 100 members to …

Ninety-three thromboembolic occlusions of peripheral arteries or grafts in 85 patients were
treated with high-dose urokinase by direct intraarterial infusion. Urokinase was infused at …

Fifty-six patients, selected by clinical criteria, underwent angiography for suspected acute
mesenteric ischemia. Twenty-nine patients subsequently did not have mesenteric ischemia …

Biochemical advances are providing new insights into coagulation and fibrinolysis.
Integrating this biochemical knowledge into plasminogen activator therapy improves …

A randomized prospective trial was undertaken to compare intraarterial administration of
recombinant human tissue-type plasminogen activator (rt-PA) with urokinase (UK) in 32 …

Three patients, ages 51 to 71 years, sought treatment for symptomatic dural sinus
thrombosis with occlusion and were treated by direct sinus perfusion with urokinase. All …

The charts of 79 patients who required femoral arterial (FA) thrombectomy after cardiac
catheterization were reviewed. Fifteen patients (19%) had poor pulses after thrombectomy …

The aim of this paper is to develop an intercontinental consensus on the use of thrombolytic
therapy in occlusive peripheral arterial disease affecting lower limbs. A working party of self …

In a retrospective analysis, the efficacy of lysis, the degree of systemic thrombolytic effect,
and the rate of complications during local thrombolytic therapy with either streptokinase (SK) …